Peter A. Ljubenkov

Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial

Günter U. Höglinger, Irene Litvan, Nuno Mendonça et al. · The Lancet Neurology · 2021 · 130 citations · Full text

Clinical Trials, Progressive Supranuclear Palsy, Placebo-controlled Trial +7

Temporal order of clinical and biomarker changes in familial frontotemporal dementia

Adam M. Staffaroni, Melanie Quintana, Barbara Wendelberger et al. · Nature Medicine · 2022 · 128 citations · Full text

Alzheimer's Disease, Dementia, Temporal Order +9

Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome

Richard Tsai, Zachary Miller, Mary Koestler et al. · JAMA Neurology · 2019 · 118 citations · Full text

Longitudinal multimodal imaging and clinical endpoints for frontotemporal dementia clinical trials

Adam M. Staffaroni, Peter A. Ljubenkov, John Kornak et al. · Brain · 2018 · 105 citations · Full text

Neuropsychology, Longitudinal Multimodal Imaging, Corticobasal Degeneration +20

Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration

Julio C. Rojas, Ping Wang, Adam M. Staffaroni et al. · Neurology · 2021 · 101 citations · Full text